Literature DB >> 24071934

Clinical implementation of musculoskeletal ultrasound in rheumatology in Austria.

Christina Duftner1, Claudia Schüller-Weidekamm, Peter Mandl, Thomas Nothnagl, Michael Schirmer, Franz Kainberger, Klaus Machold, Christian Dejaco.   

Abstract

The aim of the study is to assess the clinical implementation of musculoskeletal ultrasound (MSUS) in rheumatology in Austria. A survey was conducted among Austrian rheumatologists and physicians of other specialties with a focus on rheumatology. The questionnaire was designed by the members of the Austrian Radiology-Rheumatology Initiative for Musculoskeletal UltraSound including the following items: demographics, access to MSUS and MSUS training, application of MSUS to support diagnosis, monitoring and treatment decisions, and obstacles for the routine performance of MSUS. Eighty-eight (21.9 %) out of the 402 surveyed physicians responded. No access to MSUS and/or inadequate training in the technique was more commonly reported by senior (>50 years; 64.3 and 67.7 %, respectively) than by younger physicians (16.7 %, p = 0.01 and 18.5 %, p < 0.001, respectively). The lowest availability of sonography was found among senior rheumatologists (25.0 %, p = 0.001 compared to the total group). MSUS is routinely used for diagnosis and/or monitoring purposes by 12.5 % of physicians and 20.5 % perform sonography in clinically unclear cases. A limited number of physicians apply the method to support treatment decisions and/or to evaluate treatment success. The most important obstacles for routine application of MSUS in rheumatology are limited access to ultrasound machines, lack of training/education in the technique, and time constraints in daily routine. Low access to high-end ultrasound devices, lack of training, and time constraints may explain the low appreciation of MSUS among Austrian physicians evaluating patients with rheumatic diseases.

Entities:  

Mesh:

Year:  2013        PMID: 24071934     DOI: 10.1007/s00296-013-2863-4

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  14 in total

1.  Musculoskeletal ultrasonography in Europe: results of a rheumatologist-based survey at a EULAR meeting.

Authors:  R J Wakefield; E Goh; P G Conaghan; Z Karim; P Emery
Journal:  Rheumatology (Oxford)       Date:  2003-06-16       Impact factor: 7.580

2.  Current state of musculoskeletal ultrasound training and implementation in Europe: results of a survey of experts and scientific societies.

Authors:  Esperanza Naredo; Maria A D'Agostino; Philip G Conaghan; Marina Backhaus; Peter Balint; George A W Bruyn; Emilio Filippucci; Walter Grassi; Hilde B Hammer; Annamaria Iagnocco; David Kane; Juhani M Koski; Marcin Szkudlarek; Lene Terslev; Richard J Wakefield; Hans-Rudolf Ziswiler; Wolfgang A Schmidt
Journal:  Rheumatology (Oxford)       Date:  2010-09-13       Impact factor: 7.580

3.  The use of musculoskeletal ultrasound by rheumatologists in the United States.

Authors:  Jonathan Samuels; Steven B Abramson; Gurjit S Kaeley
Journal:  Bull NYU Hosp Jt Dis       Date:  2010

Review 4.  Ultrasonography in inflammatory rheumatic disease: an overview.

Authors:  Michael Schirmer; Christina Duftner; Wolfgang A Schmidt; Christian Dejaco
Journal:  Nat Rev Rheumatol       Date:  2011-07-12       Impact factor: 20.543

5.  Ultrasonographic evaluation of joint involvement in early rheumatoid arthritis in clinical remission: power Doppler signal predicts short-term relapse.

Authors:  Carlo A Scirè; Carlomaurizio Montecucco; Veronica Codullo; Oscar Epis; Monica Todoerti; Roberto Caporali
Journal:  Rheumatology (Oxford)       Date:  2009-06-26       Impact factor: 7.580

6.  Metrologic properties of ultrasound versus clinical evaluation of synovitis in rheumatoid arthritis: results of a multicenter, randomized study.

Authors:  P Mandl; P V Balint; Y Brault; M Backhaus; M-A D'Agostino; W Grassi; D van der Heijde; E de Miguel; R J Wakefield; I Logeart; M Dougados
Journal:  Arthritis Rheum       Date:  2011-11-30

7.  Presence of significant synovitis in rheumatoid arthritis patients with disease-modifying antirheumatic drug-induced clinical remission: evidence from an imaging study may explain structural progression.

Authors:  A K Brown; M A Quinn; Z Karim; P G Conaghan; C G Peterfy; E Hensor; R J Wakefield; P J O'Connor; P Emery
Journal:  Arthritis Rheum       Date:  2006-12

8.  Musculoskeletal ultrasonography in Romania - results from a specific questionnaire.

Authors:  Maria Magdalena Tamas; Daniela Fodor; Nicolae Rednic; Simona Rednic
Journal:  Med Ultrason       Date:  2011-03       Impact factor: 1.611

Review 9.  After treat-to-target: can a targeted ultrasound initiative improve RA outcomes?

Authors:  Richard J Wakefield; Maria Antonietta D'Agostino; Esperanza Naredo; Maya H Buch; Annamaria Iagnocco; Lene Terslev; Mikkel Ostergaard; Marina Backhaus; Walter Grassi; Maxime Dougados; Gerd R Burmester; Benazir Saleem; Eugenio de Miguel; Cristina Estrach; Kei Ikeda; Marwin Gutierrez; Robert Thompson; Peter Balint; Paul Emery
Journal:  Ann Rheum Dis       Date:  2012-05-05       Impact factor: 19.103

10.  Can flare be predicted in DMARD treated RA patients in remission, and is it important? A cohort study.

Authors:  Benazir Saleem; Andrew K Brown; Mark Quinn; Zunaid Karim; Elizabeth M A Hensor; Philip Conaghan; Charles Peterfy; Richard J Wakefield; Paul Emery
Journal:  Ann Rheum Dis       Date:  2012-01-31       Impact factor: 19.103

View more
  2 in total

1.  [Diagnosis and management of gout in Austria. Survey of current practice considering the EULAR recommendations].

Authors:  J Sautner
Journal:  Z Rheumatol       Date:  2014-11       Impact factor: 1.372

2.  Performance of a Handheld Ultrasound Device to Assess Articular and Periarticular Pathologies in Patients with Inflammatory Arthritis.

Authors:  Giulia Corte; Sara Bayat; Koray Tascilar; Larissa Valor-Mendez; Louis Schuster; Johannes Knitza; Filippo Fagni; Georg Schett; Arnd Kleyer; David Simon
Journal:  Diagnostics (Basel)       Date:  2021-06-22
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.